vatalanib has been researched along with Pregnancy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachelier, R; Clézardin, P; Confavreux, CB; Croset, M; Goehrig, D; Peyruchaud, O; van der Pluijm, G | 1 |
| Adeoye, OO; Butler, SM; Hubbell, MC; Khorram, O; Pearce, WJ; Semotiuk, AJ; Thorpe, RB; Williams, JM | 1 |
2 other study(ies) available for vatalanib and Pregnancy
| Article | Year |
|---|---|
Combination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Breast Neoplasms; Female; Human Umbilical Vein Endothelial Cells; Humans; Immunocompromised Host; Mice; Mice, Inbred C3H; Osteolysis; Phthalazines; Pregnancy; Pyridines; Receptors, Vascular Endothelial Growth Factor; RNA, Small Interfering; Transfection; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |
Chronic hypoxia and VEGF differentially modulate abundance and organization of myosin heavy chain isoforms in fetal and adult ovine arteries.
Topics: Animals; Arteries; Female; Fetus; Hypoxia; Myosin Heavy Chains; Oxygen; Phthalazines; Pregnancy; Protein Kinase Inhibitors; Protein Transport; Pyridines; Receptors, Vascular Endothelial Growth Factor; Sheep; Vascular Endothelial Growth Factor A | 2012 |